Nationality: German/New Zealander | Year of birth: 1959
As co-founder and CEO of MorphoSys AG, Simon Moroney played a central role in establishing the company as a force in the field of therapeutic antibodies, with one of the broadest pipelines of drug candidates in the industry. Mr. Moroney holds both a doctorate and a Master of Science in chemistry.
Co-founder and CEO, MorphoSys AG, Germany (1992–2019)
Research associate, Department of Pharmacology, University of Cambridge, UK (1991–1992)
Assistant professor, Department of Chemistry, University of British Columbia, Canada (1989–1990)
Doctorate in chemistry, University of Oxford, UK
Master of Science in chemistry, University of Waikato, New Zealand
Chairman of the board of directors, Biotalys NV, Belgium